XRCC3 Thr241Met polymorphism and response to platinum-based chemotherapy.

*significant difference; Homozygote Comparison: MetMet vs. ThrThr; Heterozygote Comparison: ThrMet vs. ThrThr; Recessive Model: MetMet vs. ThrMet/ThrThr; Dominant Model: ThrMet/MetMet vs. ThrThr; OR: odds ratio; CI: confidence intervals; P: p value of heterogeneity; NA: not available.*显著性差异；纯合子比较：MetMet 与 ThrThr；杂合子比较：ThrMet 与 ThrThr；隐性遗传模型：MetMet 与 ThrMet/ThrThr；显性遗传模型：ThrMet/MetMet 与 ThrThr；比值比（odds ratio，OR）；置信区间（confidence intervals，CI）；异质性检验p值（p value of heterogeneity，P）；无可用数据（not available，NA）。